You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
19 May 2026 - Clinical-stage biotechnology company Nanjing Leads Biolabs Co Ltd (HK:9887) announced on Monday that its proprietary PD-L1/4-1BB bispecific antibody, Opamtistomig (LBL-024), has received approval from the Center for Drug Evaluation (CDE...
19 May 2026 - Clinical-stage biotechnology company Accro Bioscience Inc announced on Monday the closing of its USD50m Series C financing.The round was led by OrbiMed, with participation from TCG Crossover, LAV, Cenova Capital, and existing investors ...
18 May 2026 - Biosensing technology company DexCom Inc (Nasdaq: DXCM) announced on Monday that it has introduced Dexcom Flex, a new continuous glucose monitoring system designed for adults with Type 2 diabetes who are not on intensive insulin therapy...
18 May 2026 - Biotechnology company ImmunityBio Inc (NASDAQ: IBRX) announced on Monday the issuance of five US patents covering the combination of its IL-15 receptor agonist ANKTIVA with Bacillus Calmette-Guérin (BCG) for the treatment of non-...
18 May 2026 - Endospan, a pioneer in endovascular solutions for complex aortic pathologies, announced on Monday that it has been acquired by medical device company Artivion Inc (NYSE: AORT) following US Food and Drug Administration premarket approval...
18 May 2026 - Biopharmaceutical company AstraZeneca plc (LSE: AZN) (STO: AZN) (NYSE: AZN) reported on Monday that it has received US Food and Drug Administration approval for Baxfendy (baxdrostat), the first and only aldosterone synthase inhibitor fo...
18 May 2026 - CTC intelligence company CelLBxHealth plc (AIM: CLBX) announced on Monday that it has entered a collaboration with AdventHealth, a US-based faith-based health system, to use its Parsortix platform in two clinical studies focused on mini...